Appeal No. 94-2100
Application 07/902,109
older subjects were significantly more impaired than the
younger by scopolamine on some tests of learning and memory.
This increased sensitivity of the older group to scopolamine
is consistent with studies in animals and humans showing
decreased cholinergic system function with age. The
findings also indicate that age is an important variable to
consider in using the scopolamine model of memory
impairment.
Thus, absent evidence to the contrary, we hold that the
appellant’s specification would have enabled one skilled in the
art to “make and use” the claimed compositions at the time the
application was filed.
Accordingly, decision of the examiner is reversed.
REVERSED
)
TEDDY S. GRON )
Administrative Patent Judge )
)
)
) BOARD OF PATENT
CHUNG K. PAK )
Administrative Patent Judge ) APPEALS AND
)
) INTERFERENCES
)
JOAN ELLIS )
Administrative Patent Judge )
8
Page: Previous 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007